APA

Rosen P. J., Rankin C., Head D. R., Boldt D. H., Luthardt F. W., Norwood T., Pugh R. P., Karanes C. & Appelbaum F. R. (20000411). A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia. : Leukemia research.

Chicago

Rosen P J, Rankin C, Head D R, Boldt D H, Luthardt F W, Norwood T, Pugh R P, Karanes C and Appelbaum F R. 20000411. A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia. : Leukemia research.

Harvard

Rosen P. J., Rankin C., Head D. R., Boldt D. H., Luthardt F. W., Norwood T., Pugh R. P., Karanes C. and Appelbaum F. R. (20000411). A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia. : Leukemia research.

MLA

Rosen P J, Rankin C, Head D R, Boldt D H, Luthardt F W, Norwood T, Pugh R P, Karanes C and Appelbaum F R. A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia. : Leukemia research. 20000411.